Skip to main navigation Skip to search Skip to main content

Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.

Translated title of the contribution: Low doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.
  • J.E. Arends
  • , A.I.M. Hoepelman
  • , N.M. Nanlohy
  • , F.J.P. Höppener
  • , K.R. Hirsch
  • , J.G. Park
  • , D. van Baarle

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionLow doses of the novel caspase-inhibitor GS-9450 leads to lower caspase-3 and -8 expression on peripheral CD4+ and CD8+ T-cells.
Original languageUndefined/Unknown
Pages (from-to)959-966
Number of pages8
JournalApoptosis
Volume16
Issue number9
Publication statusPublished - 2011

Cite this